Multiplex Enhanced Reduced Representation Bisulfite Sequencing (mERRBS)  longitudinal analysis of adult Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) with 1q jumping translocation after 5'-azacytidine treatment compared to controls
Jumping translocations are cytogenetic abnormalities associated with poor clinical outcome and progression in Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML).Typically a donor chromosome, often a trisomic 1q, is transferred onto 2 or more recipient chromosomes. Previous studies have demonstrated the crosstalk between DNA hypomethylation and 1q trisomy. Here, we used an epi-genomic approach in sequential samples from a cohort of MDS and AML with the appearance of 1q jumping translocations after 5'-azacytidine (AZA) treatment. Overall design: mERRBS profiles of 3 MDS and AML cases with 1q jumping translocation at 3 timepoints ,  and 3 controls (bone marrow samples from non-neoplastic cytopenias, normal bone marrow morphology and normal karyotype)